• IE of PFO devices is rare but devastating and necessitates surgical removal. • Guidelines specify antibiotics for dental work, but epidural abscesses cause IE too. • Incomplete NE of PFO devices is an independent risk factor for IE. • Assessing NE after PFO closure may help individualize IE risk. • Patients with intracardiac devices need counseling on dental and skin hygiene.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227997 | PMC |
| http://dx.doi.org/10.1016/j.case.2024.03.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Arrhythmias Following Patent Foramen Ovale Closure: An Unsolved Enigma.
Life (Basel)
December 2024
First Department of Cardiology, Hippokration Hospital, Athens Medical School, National and Kapodistrian University of Athens, Vas. Sofias 114, 11527 Athens, Greece.
Patent foramen ovale (PFO) closure has proven to be an effective method of reducing the risk of recurrent stroke in patients with embolic stroke of unknown origin (ESUS). One of the most recognized post-procedural complications is the de novo occurrence of supraventricular arrhythmias, mainly atrial fibrillation, in the first three months following PFO closure. Earlier studies reported the incidence to be around 3.
View Article and Find Full Text PDFSurgical Explantation of an Amplatzer Device for Patent Foramen Ovale Closure in a Patient With Nickel Allergy: A Case Report.
Clin Case Rep
December 2024
Department of Cardiothoracic Surgery HonorHealth Scottsdale Arizona USA.
Patent foramen ovale (PFO) closure using percutaneous devices, such as the Amplatzer occluder, is a common treatment for patients with a history of cryptogenic stroke or transient ischemic attack (TIA). Although generally well-tolerated, some patients may develop adverse reactions to the device materials, particularly in the presence of a nickel allergy. Symptoms can include chest pain, rashes, and migraines, which may necessitate surgical removal of the device.
View Article and Find Full Text PDFPresence of patent foramen ovale does not increase cerebrovascular event rates in patients with atrial fibrillation following left atrial appendage closure.
Heliyon
November 2024
Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, Hubei Province, 430022, China.
Article Synopsis
- The study investigates the relationship between atrial fibrillation (AF) and patent foramen ovale (PFO) regarding the risk of ischemic stroke, focusing on whether closing PFO is necessary for stroke prevention in AF patients undergoing left atrial appendage closure (LAAC).
- Researchers analyzed clinical data from 614 patients who underwent LAAC to compare outcomes between AF patients with PFO and those without, particularly looking at ischemic stroke rates and major adverse cardiovascular events (MACEs).
- The findings indicate that there is no significant difference in stroke rates or MACEs between patients with and without PFO, suggesting that PFO closure may not be necessary for stroke prevention in AF patients after LAAC.
Patent Foramen Ovale (PFO): History, Diagnosis, and Management.
Rev Cardiovasc Med
November 2024
Department of Internal Medicine I, Cardiology, Angiology, Intensive Medical Care, University Hospital Jena, 07747 Jena, Germany.
Article Synopsis
- Current guidelines suggest closing a patent foramen ovale (PFO) in patients aged 16-60 who have had a cryptogenic or cardioembolic stroke and have a high-risk PFO, based on strong evidence.
- The efficacy of PFO closure varies, with studies like the CLOSE and RESPECT trials showing a number needed-to-treat (NNT) of 20 to 44 over five years, while the REDUCE trial indicated an NNT as low as 18 over ten years.
- Although interventional PFO closure is relatively easy to learn, it requires careful execution to reduce complications; research is ongoing for its use in treating migraines, but closures for non-stroke reasons should be evaluated individually.
Incomplete cor triatriatum dexter and percutaneous closure of atrial septal defects, a single-centre experience.
Acta Cardiol
November 2024
Interventional Cardiology Unit, Miguel Servet University Hospital, Zaragoza, Spain.
Article Synopsis
- Cor Triatriatum Dexter (CTD) is a rare heart defect that splits the right atrium into two chambers, with a milder version called incomplete CTD (CTDi) that only partially divides it.
- CTDi can be linked to interatrial septal defects and often presents in adults who experience cryptogenic strokes, usually leading to referrals for closure of a patent foramen ovale (PFO).
- Successful PFO closure in patients with CTDi can be challenging due to complications in visualization and device deployment, making advanced imaging techniques and careful planning essential for positive outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!